Entering text into the input field will update the search result below

Echo Therapeutics reports FY'14 results

  • Echo Therapeutics (OTC:ECTE): FY'14 EPS of -$1.24 vs. -$2.33 in FY'13
  • Revenue of $57K (+111.1% Y/Y).
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ECTE--
Echo Therapeutics, Inc.